Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)
Clinical trial NCT03258359 · UNKNOWN
Trial details
- NCT number
- NCT03258359
- Sponsor
- PersImmune, Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2020-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.